MedTrace Logo

Dragon Ambient eXperience (DAX) Copilot Evaluation

NCT06329427 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 238

Last updated 2024-03-29

No results posted yet for this study

Summary

AI solutions like, Dragon Ambient eXperience (DAX) Copilot (Nuance/Microsoft), hold the potential to significantly enhance provider and patient interactions and alleviate pain points that contribute to burn out. Atrium Health was the first healthcare system in the world to pilot Nuance's DAX Copilot intelligence (AI) enabled scribe software, which synthesizes a draft clinic note by "listening" to the conversation between a provider and patient. After 180 days of use by primary care clinicians and advanced practice providers (APPs), along with a control group, the investigators assess provider satisfaction, patient experience, and provider efficiency through qualitative and quantitative methods.

Conditions

  • Automated Clinical Documentation

Interventions

OTHER

Dragon Ambient eXperience (DAX) Copilot

The tool (DAX) listens to the conversation between a clinician and patient/caregiver during their visit, provides transcriptions between different speakers for the clinician to review, edit, and included in the final EHR notes.

Sponsors & Collaborators

  • Hieu Nguyen, MS - Biostatician

    collaborator UNKNOWN

  • McKenzie Isreal, MPH - project manager

    collaborator UNKNOWN

  • Casey Stephens, MPH - Health services researcher

    collaborator UNKNOWN

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Tsai-Ling Liu, PhD · Wake Forest University Health Sciences

  • Timothy C Hetherington, MS · Wake Forest University Health Sciences

  • Jeffrey A. Cleveland, MD, FAAP · Wake Forest University Health Sciences

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-19
Primary Completion
2023-12-15
Completion
2023-12-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06329427 on ClinicalTrials.gov